Attend the FIRST clinical operations event of 2018 on January 23–25 at The Westin Philadelphia! Now in its 7th year, the CROWN Congress attracts senior-level clinical leaders creating an intimate and ideal forum to share, learn, network, and engage on how to advance the industry and optimize clinical trial operations. Send your entire team to our three-day conference featuring three tracks, 30+ educational sessions, 40+ expert speakers, and our unique keynote panel of well-known industry leaders on “Breaking the Outsourcing Mold.” Register today to secure your seat!
Attend the only event on clinical trial billing February 25–28, 2018 at the Wyndham Lake Buena Vista Disney Springs Resort in Orlando. Now in its 12th year, the Clinical Trial Billing & Research Compliance Conference will share best practices on how to increase your revenue and monitor billing integrity. Send your entire team to a full four-day conference featuring 25+ educational sessions, 40+ expert speakers, and 250+ attendees. This program also has the prior approval of AAPC for 29 continuing education hours (CEUs) as well as 24.9 continuing education credits (CCB). Register today and join us!
The Cannabis Partnerships Congress (March 12–13, San Francisco) brings together stakeholders involved in Cannabis-based scientific, medicinal, governmental, and research development as to fortify the therapies in a collaborative environment. With the continued enforcement of restrictive policies and regulations on research into the health benefits, it is important for those involved to understand the obstacles in order to enhance product development.
This conference will showcase how to overcome legislative hurdles and current and planned cannabinoid research, and how to improve the quality and efficiency of data integrity in clinical trials.
Successfully introducing new drugs and therapies in a quicker and more cost-effective manner starts in the most complex phase on of drug development; the clinical phase. The implementation of risk-based monitoring increases the overall quality of data while providing better oversight of patient safety. With the introduction of centralized monitoring in a risk-based monitoring approach, pharmaceutical companies are able to embrace a real-time overview of data and risk detection.
The Central Monitoring Summit will arm delegates with the tools they need to optimize existing clinical operation platforms and build quality into the design for a sound central monitoring foundation. Join your colleagues and our expert speaking staff as they provide in-depth insights into shifting your monitoring processes from an excessive concentration of data to risk-driven monitoring that uses central monitoring and technology enablement.
Digital Pharma, the leading event series for life science marketers, is proud to bring our latest event to Japan. Join us April 9–10 at the Westin Tokyo for the inaugural Digital Pharma Japan. Our expert speaker faculty of regional and international industry leaders will share successful digital tools and techniques that can be leveraged to bridge the gap between more digitally mature markets in order to achieve full integration of marketing capabilities in the Japanese market. Reserve your seat today!
Kelly Willenberg LLC is a full service research compliance organization serving clients on improving operations. She employs technologies to improve operational aspects of compliance based on client needs. She assists in the implementation of billing compliance programs, offers training seminars, builds coverage analysis and helps with process improvement. She can also assist with process improvement, quality assurance and assessing vulnerabilities in all aspects of research compliance.
FiercePharma is a digital media publication, reporting and delivering daily news and objective analysis for business professionals in global industries. FiercePharma offers broad coverage serving a wide range of specific functional interests, including manufacturing regulation, financial management, quality control and production methods; shareholder pressure and speed-to-market strategies; sales and marketing access to physicians and navigating payer rules; the impact of pricing and partnerships on the pipeline; and the influence of big data, executive moves and social media on it all.
MAPS is the premier non-profit global society of Medical Affairs professionals across a spectrum of fields, experience, and locales. With our non-profit status, MAPS is able to reinvest all revenue back into the society, which ensures our ability to create valuable programs and resources that support the Medical Affairs community. MAPS is transforming the Medical Affairs industry to increase its value to companies and, ultimately, benefit patients and consumers.
From the Creators of Digital Pharma: The Disease Awareness Campaigns Forum
Disease awareness campaigns have long been used by the industry to disseminate unbranded, educational information about the burden of a disease state. Before launching educational campaigns, all team members should understand how to educate their audience about a condition outside of a clinical setting, in a way that is meaningful and relevant.
In addition to conferences, ExL Events also provides industry-related content through a variety of social platforms. Be sure to follow the profiles that fit your topics of interest to gain access to the latest content and industry news.
Fill out our form to receive topic-specific conference emails as well as updates.